Johnson Philip L 4

What Happened

• Philip L. Johnson, Chief Financial Officer of Jazz Pharmaceuticals plc, had 2,615 shares withheld to satisfy tax obligations tied to the vesting of previously granted restricted stock units. The withheld shares were valued at $188.69 each, for a total of about $493,424. This was a tax-withholding disposition (not an open-market sale).

Key Details

• Transaction date: 2026-03-05
• Filing date: 2026-03-09 (Form 4 accession 0002013156-26-000004)
• Shares withheld/disposed: 2,615
• Price per share: $188.69
• Total value: $493,424 (approx.)
• Transaction code: F (shares withheld to satisfy tax obligations)
• Footnote: F1 — shares withheld to satisfy tax obligations arising from vesting of restricted stock units
• Shares owned after the transaction: not specified in the provided filing excerpt
• No late-filing flag was provided in the excerpt

Context

• This was a routine tax-withholding event associated with RSU vesting (a common administrative disposition). It does not represent an open-market sale by the insider and is generally not considered a directional signal about the insider's view of the company.